Literature DB >> 12552559

Comprehensive scanning of the ATM gene with DOVAM-S.

Carolyn H Buzin1, Richard A Gatti, Vu Q Nguyen, Cindy Y Wen, Midori Mitui, Ozden Sanal, Jie Sheng Chen, Guity Nozari, April Mengos, Xuemin Li, Frank Fujimura, Steve S Sommer.   

Abstract

Mutation detection at the ATM locus has been difficult because of the large size of the gene (66 exons), the fact that mutations are located throughout the entire gene with no hotspots, and the difficulty of distinguishing mutations from polymorphisms. In this study, the entire coding region (exons 4-65) was scanned, as well as the adjacent intronic regions, using DOVAM-S (Detection Of Virtually All Mutations-SSCP), a robotically-enhanced, multiplexed scanning method that is a highly sensitive modification of SSCP. Forty-three unrelated patients and four obligate carriers were studied. Of the 90 expected mutant alleles, 71 were identified (79%). The mutations included 17 nonsense (24%), 20 frameshift (28%), 20 splice (28%), 10 missense (14%), one in-frame deletion (1%), and three that alter the initiation codon (4%). Among the ataxia-telangiectasia patients, two potentially causative mutations were identified in 30 individuals: 22 had two truncating mutations, four had one truncating and one missense mutation, three had two missense mutations, and one had a truncating mutation and an in-frame deletion of three amino acids. For seven A-T patients and all four obligate carriers, only one truncating mutation was detected. Six of the 43 A-T patients had no detected mutations (14%). Twelve novel mutations and six novel polymorphisms were detected. The results of this complete scan of the ATM coding region showed that 86% of causative ATM mutations were truncating and 14% were missense. DOVAM-S is a rapid, efficient method of performing A-T diagnosis and carrier testing on a clinical time scale. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552559     DOI: 10.1002/humu.10158

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  Molecular defects in Moroccan patients with ataxia-telangiectasia.

Authors:  L Jeddane; F Ailal; C Dubois-d'Enghien; O Abidi; I Benhsaien; A Kili; S Chaouki; Y Kriouile; N El Hafidi; H Fadil; R Abilkassem; N Rada; A A Bousfiha; A Barakat; D Stoppa-Lyonnet; H Bellaoui
Journal:  Neuromolecular Med       Date:  2013-01-16       Impact factor: 3.843

2.  Prominent oromandibular dystonia and pharyngeal telangiectasia in atypical ataxia telangiectasia.

Authors:  Fatima Carrillo; Susanne A Schneider; A Malcolm R Taylor; Venkataramanan Srinivasan; Raj Kapoor; Kailash P Bhatia
Journal:  Cerebellum       Date:  2009-03       Impact factor: 3.847

3.  Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.

Authors:  M Mitui; S A Nahas; L T Du; Z Yang; C H Lai; K Nakamura; S Arroyo; S Scott; A Purayidom; P Concannon; M Lavin; R A Gatti
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

4.  Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.

Authors:  Allison W Kurian; Emily E Hare; Meredith A Mills; Kerry E Kingham; Lisa McPherson; Alice S Whittemore; Valerie McGuire; Uri Ladabaum; Yuya Kobayashi; Stephen E Lincoln; Michele Cargill; James M Ford
Journal:  J Clin Oncol       Date:  2014-04-14       Impact factor: 44.544

5.  A novel approach to describe a U1 snRNA binding site.

Authors:  Marcel Freund; Corinna Asang; Susanne Kammler; Carolin Konermann; Jörg Krummheuer; Marianne Hipp; Imke Meyer; Wolfram Gierling; Stephan Theiss; Thorsten Preuss; Detlev Schindler; Jørgen Kjems; Heiner Schaal
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

6.  Ten new ATM alterations in Polish patients with ataxia-telangiectasia.

Authors:  Marta Joanna Podralska; Agnieszka Stembalska; Ryszard Ślęzak; Aleksandra Lewandowicz-Uszyńska; Barbara Pietrucha; Sylwia Kołtan; Jadwiga Wigowska-Sowińska; Jacek Pilch; Maria Mosor; Iwona Ziółkowska-Suchanek; Agnieszka Dzikiewicz-Krawczyk; Ryszard Słomski
Journal:  Mol Genet Genomic Med       Date:  2014-07-30       Impact factor: 2.183

7.  Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants.

Authors:  Elena Bueno-Martínez; Lara Sanoguera-Miralles; Alberto Valenzuela-Palomo; Ada Esteban-Sánchez; Víctor Lorca; Inés Llinares-Burguet; Jamie Allen; Alicia García-Álvarez; Pedro Pérez-Segura; Mercedes Durán; Douglas F Easton; Peter Devilee; Maaike Pg Vreeswijk; Miguel de la Hoya; Eladio A Velasco-Sampedro
Journal:  J Pathol       Date:  2022-07-15       Impact factor: 9.883

8.  Molecular variants of the ATM gene in Hodgkin's disease in children.

Authors:  E Liberzon; S Avigad; I Yaniv; B Stark; G Avrahami; Y Goshen; R Zaizov
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.